Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: The VAST study

This publication has 22 references indexed in Scilit:

• Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy
  JACC, 2004
• Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both
  Clinical Therapeutics, 2004
• Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysis
  European Heart Journal, 2004
• Hypertension control – an old song resung
  Blood Pressure, 2004
• A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study
  Clinical Therapeutics, 2003
• 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*
  Journal Of Hypertension, 2003
• Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild‐to‐moderately hypertensive Brazilian population
  Blood Pressure, 2003
• Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan Monotherapy
  Blood Pressure, 2003
• Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  The Journal of Clinical Hypertension, 2002
• Fibrinolysis and thrombosis
  Best Practice & Research Clinical Haematology, 1999